1 Table of Contents
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Wound Closure Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Wound Closure Devices Market, United States_x000D_
3.1 Wound Closure Devices Market, United States, Revenue ($m), 2018-2033_x000D_
3.1.1 Ligating Clips Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
3.1.2 Membrane Surgical Adhesion Barriers Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
3.1.3 Tissue Sealants and Adhesives Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
3.1.4 Topical Absorbable Hemostats Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
3.2 Wound Closure Devices Market, United States, Volume (Units), 2018-2033_x000D_
3.2.1 Ligating Clips Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
3.2.2 Membrane Surgical Adhesion Barriers Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
3.2.3 Tissue Sealants and Adhesives Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
3.2.4 Topical Absorbable Hemostats Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
3.3 Wound Closure Devices Market, United States, Average Price ($) , 2018-2033_x000D_
3.4 Wound Closure Devices Market, United States, Company Share by Revenue ($m), 2024_x000D_
4 Overview of Key Companies in United States, Wound Closure Devices Market_x000D_
4.1 Baxter International Inc_x000D_
4.1.1 Company Overview_x000D_
4.2 Ethicon Inc_x000D_
4.2.1 Company Overview_x000D_
4.3 Cardinal Health Inc_x000D_
4.3.1 Company Overview_x000D_
4.4 CR Bard Inc_x000D_
4.4.1 Company Overview_x000D_
4.5 Integra LifeSciences Holdings Corp_x000D_
4.5.1 Company Overview_x000D_
4.6 B. Braun Melsungen AG_x000D_
4.6.1 Company Overview_x000D_
4.7 Solventum Corp_x000D_
4.7.1 Company Overview_x000D_
4.8 Teleflex Inc_x000D_
4.8.1 Company Overview_x000D_
4.9 Medtronic Plc_x000D_
4.9.1 Company Overview_x000D_
4.10 W. L. Gore & Associates Inc_x000D_
4.10.1 Company Overview_x000D_
5 Wound Closure Devices Market Pipeline Products_x000D_
6 Recent Developments_x000D_
6.1 Corporate Communications_x000D_
6.1.1 Oct 28, 2025: Medela AG Launches Campaign to Celebrate the Journey of Motherhood_x000D_
6.1.2 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds_x000D_
6.1.3 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed_x000D_
6.1.4 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio_x000D_
6.2 Financial Announcements_x000D_
6.2.1 Jan 22, 2025: Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors_x000D_
6.2.2 Oct 30, 2024: MIMEDX Reports Q3 2024 Operating and Financial Results_x000D_
6.3 Government and Public Interest_x000D_
6.3.1 Sep 23, 2025: FibroBiologics To Present At 2025 Cell & Gene Meeting On The Mesa_x000D_
6.3.2 Feb 17, 2025: Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference_x000D_
6.3.3 Dec 18, 2024: Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference_x000D_
6.3.4 Nov 12, 2024: Baxter to Present at Stifel 2024 Healthcare Conference_x000D_
6.4 Other Significant Developments_x000D_
6.4.1 Oct 02, 2025: SS Innovations Provides U.S. Regulatory Update for SSi Mantra Surgical Robotic System_x000D_
6.4.2 Oct 02, 2025: BioStem Technologies Partners with Florida Panthers for 13th Season of 'Heroes Among Us' Program_x000D_
6.4.3 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds_x000D_
6.4.4 Sep 24, 2025: Medline Secures Prime Vendor Agreement With Commonheart_x000D_
6.4.5 Sep 22, 2025: The Plastic Surgery Center Launches Got-A-Cut Program for Quick Pediatric Stitches_x000D_
6.5 Product News_x000D_
6.5.1 Oct 28, 2025: Medela AG Launches Campaign to Celebrate the Journey of Motherhood_x000D_
6.5.2 Oct 28, 2025: NeXtGen Biologics Completes First FDA Audit with Zero Observations_x000D_
6.5.3 Oct 13, 2025: BioLargo Subsidiary Clyra Medical Advances Toward Product Launches and Expansion_x000D_
6.5.4 Oct 02, 2025: SS Innovations Provides U.S. Regulatory Update for SSi Mantra Surgical Robotic System_x000D_
6.5.5 Oct 01, 2025: FDA Grants Clearance For Planmed XFI Full-Body Weight-Bearing CT Scanner_x000D_
6.5.6 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds_x000D_
6.5.7 Sep 30, 2025: Sona Launches Brand Partnerships Program, Offering Expecting Parents Over $300 in Perks_x000D_
6.5.8 Sep 29, 2025: Izotropic Corporation Anticipates Tomorrow’s Imaging Standards_x000D_
6.5.9 Sep 25, 2025: MediWound Receives TGA Approval for NexoBrid in Australia_x000D_
6.5.10 Sep 10, 2025: Spartan Medical Partners With NATROX to Provide Continuous Topical Oxygen Therapy to Veterans and Federal Facilities_x000D_
6.5.11 Sep 10, 2025: Kane Biotech Completes Enrollment in U.S. Case Series Studies of Its Revyve Antimicrobial Wound Gel and Spray_x000D_
6.5.12 Nov 18, 2024: Humabiologics Secures Two Patents for Breakthrough Human Biomaterial Production_x000D_
6.6 Strategy And Business Planning_x000D_
6.6.1 Oct 13, 2025: BioLargo Subsidiary Clyra Medical Advances Toward Product Launches and Expansion_x000D_
6.6.2 Sep 24, 2025: Alira Health Becomes First Platinum CRO Partner of the Wound Care Collaborative Community_x000D_
6.6.3 Sep 17, 2025: Vivani Medical Sets Record Date for Cortigent Spin-off_x000D_
6.6.4 Sep 10, 2025: Spartan Medical Partners With NATROX to Provide Continuous Topical Oxygen Therapy to Veterans and Federal Facilities_x000D_
7 Appendix_x000D_
7.1 Research Methodology_x000D_
7.1.1 Coverage_x000D_
7.1.2 Secondary Research_x000D_
7.1.3 Primary Research_x000D_
7.1.4 Market Modeling and Forecasting_x000D_
7.1.5 Company Share Analysis_x000D_
7.1.6 Benchmarking_x000D_
7.2 GlobalData Consulting_x000D_
7.3 Contact Us_x000D_
7.4 Disclaimer